Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Osoba

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
VP-16 and cisplatin as first-line therapy for small-cell lung cancerW K Evans, F A Shepherd, R Feld, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 12, 2004
The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancerG Rodrigues, A Bezjak, D Osoba, et al.
Cancer|April 1, 1984
VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancerW K Evans, R Feld, D Osoba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancerD Osoba, J J Rusthoven, K A Turnbull, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 1998
The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapyJ J Rusthoven, D Osoba, C A Butts, et al.
Plastic and Reconstructive Surgery|August 1, 1987
Predictive value of staging investigations in patients with clinical stage I malignant melanomaN Iscoe, P Kersey, J Gapski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancerW K Evans, D Osoba, R Feld, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 4, 2001
Recommendations on health-related quality of life research to support labeling and promotional claims in the United StatesD A Revicki, D Osoba, D Fairclough, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 19, 1998
Effects of altering the time of administration and the time frame of quality of life assessments in clinical trials: an example using the EORTC QLQ-C30 in a large anti-emetic trialJ Pater, D Osoba, B Zee, et al.
Medical and Pediatric Oncology|January 1, 1976
The use of oral BCG in the treatment or metastatic malignant melanomaK I Pritchard, D H Cowan, M A Baker, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
VP-16 and cisplatin as first-line therapy for small-cell lung cancerW K Evans, F A Shepherd, R Feld, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 12, 2004
The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancerG Rodrigues, A Bezjak, D Osoba, et al.
Cancer|April 1, 1984
VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancerW K Evans, R Feld, D Osoba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancerD Osoba, J J Rusthoven, K A Turnbull, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 1998
The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapyJ J Rusthoven, D Osoba, C A Butts, et al.
Plastic and Reconstructive Surgery|August 1, 1987
Predictive value of staging investigations in patients with clinical stage I malignant melanomaN Iscoe, P Kersey, J Gapski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancerW K Evans, D Osoba, R Feld, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 4, 2001
Recommendations on health-related quality of life research to support labeling and promotional claims in the United StatesD A Revicki, D Osoba, D Fairclough, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 19, 1998
Effects of altering the time of administration and the time frame of quality of life assessments in clinical trials: an example using the EORTC QLQ-C30 in a large anti-emetic trialJ Pater, D Osoba, B Zee, et al.
Medical and Pediatric Oncology|January 1, 1976
The use of oral BCG in the treatment or metastatic malignant melanomaK I Pritchard, D H Cowan, M A Baker, et al.
Pageof 13